Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
Stienen S, Salah K, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Tijssen JP, Pinto YM, Kok WE. Stienen S, et al. Among authors: lazzarini v. JACC Heart Fail. 2016 Sep;4(9):736-45. doi: 10.1016/j.jchf.2016.05.007. Epub 2016 Jul 6. JACC Heart Fail. 2016. PMID: 27395353 Free article.
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K, Kok WE, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Damman P, Tijssen JG, Pinto YM. Salah K, et al. Among authors: lazzarini v. Heart. 2014 Jan;100(2):115-25. doi: 10.1136/heartjnl-2013-303632. Epub 2013 Oct 31. Heart. 2014. PMID: 24179162 Free article.
Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
Stienen S, Salah K, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Tijssen JP, Pinto YM, Kok WE. Stienen S, et al. Among authors: lazzarini v. Eur J Heart Fail. 2015 Sep;17(9):936-44. doi: 10.1002/ejhf.320. Epub 2015 Jul 29. Eur J Heart Fail. 2015. PMID: 26222618 Free article.
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.
Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L. Metra M, et al. Among authors: lazzarini v. Circ Heart Fail. 2012 Jan;5(1):54-62. doi: 10.1161/CIRCHEARTFAILURE.111.963413. Epub 2011 Dec 13. Circ Heart Fail. 2012. PMID: 22167320
Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.
Metra M, Mentz RJ, Chiswell K, Bloomfield DM, Cleland JG, Cotter G, Davison BA, Dittrich HC, Fiuzat M, Givertz MM, Lazzarini V, Mansoor GA, Massie BM, Ponikowski P, Teerlink JR, Voors AA, O'Connor CM. Metra M, et al. Among authors: lazzarini v. Eur J Heart Fail. 2015 Jan;17(1):109-18. doi: 10.1002/ejhf.207. Epub 2014 Nov 27. Eur J Heart Fail. 2015. PMID: 25431336 Free article. Clinical Trial.
Serelaxin a novel treatment for acute heart failure.
Castrini AI, Carubelli V, Lazzarini V, Bonadei I, Lombardi C, Metra M. Castrini AI, et al. Among authors: lazzarini v. Expert Rev Clin Pharmacol. 2015;8(5):549-57. doi: 10.1586/17512433.2015.1073587. Expert Rev Clin Pharmacol. 2015. PMID: 26294074 Review.
43 results